Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or vice versa? Regard L, Burgel PR, Roche N. Eur Respir J 2023;61:2202135.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Regard L, Burgel PR, Roche N. Inhaled therapy, cardiovascular risk and benefit-risk considerations in COPD: innocent until proven guilty, or vice versa? Eur Respir J 2023;61:2202135.
PMID: 36758999